Literature DB >> 24795822

The Validity and Reliability of the Sinhala Translation of the Patient Health Questionnaire (PHQ-9) and PHQ-2 Screener.

Raveen Hanwella1, Shakya Ekanayake1, Varuni A de Silva1.   

Abstract

The Patient Health Questionnaire (PHQ-9) was adapted and translated into Sinhala. Sample consisted of 75 participants diagnosed with MDD according to DSM-IV criteria and 75 gender matched controls. Concurrent validity was assessed by correlating total score of PHQ-9 with that of Centre for Epidemiological Studies Depression Scale (CESD). The Structured Clinical Interview for DSM-IV (SCID-II) conducted by a psychiatrist was the gold standard. Mean age of the sample was 33.0 years. There were 91 females (60.7%). There was significant difference in the mean PHQ-9 scores between cases (14.71) and controls (2.55) (P < 0.001). The specificity of the categorical algorithm was 0.97; the sensitivity was 0.58. Receiver operating characteristic (ROC) analysis found that cut-off score of ≥10 had sensitivity of 0.75 and specificity of 0.97. The area under the curve (AOC) was 0.93. The sensitivity of the two-item screener (PHQ-2) was 0.80 and the specificity was 0.97. Cronbach's alpha was 0.90. The PHQ-9 is a valid and reliable instrument for diagnosing MDD in a non-Western population. The threshold algorithm is recommended for screening rather than the categorical algorithm. The PHQ-2 screener has good sensitivity and specificity and is recommended as a quick screening instrument.

Entities:  

Year:  2014        PMID: 24795822      PMCID: PMC3985147          DOI: 10.1155/2014/768978

Source DB:  PubMed          Journal:  Depress Res Treat        ISSN: 2090-1321


1. Introduction

The Global Burden of Disease Study 2010 states that mental and behavioural disorders are a main contributor to Years Living with Disability (YLD) [1]. Patients with depressive symptoms present to primary care settings, specialized care units, and psychiatry treatment services [2, 3]. A WHO multicountry study reported that the prevalence of depression in primary care was 14% [4]. Depression is underdiagnosed in primary care and specialized treatment settings and only about half the patients with depression are accurately diagnosed by general practitioners [5, 6]. The Patient Health Questionnaire (PHQ-9) was developed as a screener for depression during the development of PRIME-MD [7, 8]. It is a self-administered tool based on DSM-IV criteria for diagnosing depressive disorder. It can be used to monitor severity of depression by scoring the frequency of each symptom on a scale of 0–3. It can also be used to diagnose major depressive disorder (MDD). The PHQ-9 has been used in a variety of settings. It has been translated and culturally adapted for diagnosing depressive disorder in many countries [9-11]. A meta-analysis reported that the summary sensitivity of the PHQ-9 was 0.77 (0.71–0.84) and specificity was 0.94 (0.90–0.97) [12]. The PHQ-2 is used as a screening tool for depression in primary care, and patients who screen positive are subject to further evaluation [8, 13]. This study had two main aims. The first was to establish the validity and reliability of the PHQ-9 in a Sri Lankan population. Sri Lanka has a shortage of psychiatrists and many patients with depression are treated in nonpsychiatric settings [14]. Therefore a valid and reliable depression screening instrument is invaluable in these settings. The second aim was to compare the sensitivity and specificity of the different diagnostic algorithms of the PHQ-9 which would help identify the best algorithm for diagnosis of MDD.

2. Materials and Methods

2.1. Sample

Sample size was calculated assuming a sensitivity and specificity of 0.85. Sample consisted of 75 cases diagnosed with major depressive disorder and 75 gender matched controls. Cases were selected from an outpatient psychiatry clinic in a tertiary care hospital in Colombo, Sri Lanka. Patients are referred to this clinic from other units in the hospital. Patients also directly seek treatment from this clinic. Therefore the patient population is comparable with a primary care population. Controls were selected from the community following a screening assessment to exclude depressive disorder. Patients with bipolar depression were excluded from the study.

2.2. Study Procedure

The study methodology has been described in a previous publication [15]. A combined qualitative and quantitative approach was used for the translation of the PHQ-9 [16]. A panel of six experts who were bilingual individually translated the scale into Sinhala. Sinhala is a language spoken by about 75% of Sri Lankans. The translations were then discussed in a group consisting of all six experts. The best translation for each item of the scale was decided by consensus of the group. The final translated scale was back translated to English by a bilingual expert who was unaware of the original scale. The back translated scale was compared with the original scale. The translated scale was pretested on a group of 20 people in the community. Major depressive disorder was diagnosed based on the Structured Clinical Interview for DSM-IV Disorders (SCID-1) [17]. Cases and controls completed the Sinhala version of the PHQ-9 questionnaire and the Centre for Epidemiological Studies Depression Scale (CESD) [15]. The CESD was used to assess the concurrent validity. Written informed consent was obtained from all participants and ethical approval was obtained from the Ethics Review Committee of the Faculty of Medicine, University of Colombo.

2.3. Measures

The Patient Health Questionnaire is a nine-item instrument that assesses symptoms of depression as listed in the DSM-IV. Each of the nine items is scored from 0 (not at all) to 3 (nearly every day). The total scores can range from 0 (no depressive symptoms) to 27 (all symptoms occurring daily). The PHQ-9 uses two diagnostic algorithms to diagnose MDD. The categorical algorithm requires “more than half the days” or “nearly every day” response to at least five questions which should include question 1a or 1b or both. Question 1i is counted as positive if the thought is present on several days [18]. The second algorithm uses a threshold score for diagnosis. The total score also indicates the severity of depression; scores of 0 to 4 represent a minimal level of depression; 5 to 9, mild; 10 to 14, moderate; 15 to 19, moderately severe; and 20 to 27, severe. In addition the first two questions of the PHQ-9 can be used as a screener for depressive disorder (PHQ-2) [13].

2.4. Statistical Analysis

Statistical analysis was done using SPSS Statistics version 18.0 [19]. Internal consistency was measured using Cronbach's alpha. Criterion validity was assessed using receiver operating characteristic (ROC) analysis which gave the sensitivity and specificity of the PHQ-9 at different cut-off points. The Structured Clinical Interview for DSM-IV (SCID-I) conducted by a psychiatrist was used as the gold standard [17]. Concurrent validity was assessed by correlating the total scores of CESD and PHQ-9. The sensitivity and specificity of the two algorithms of the PHQ-9 and the two-question screener (PHQ-2) in diagnosing MDD were assessed.

3. Results

The sample consisted of 75 cases and 75 controls. The mean age of the sample was 33.0 years. There were 91 females (60.7%). The controls (28.33 years) were significantly younger than the cases (37.51 years) (t = 3.48, df = 118, and P = 0.001). There was no significant difference in gender distribution between cases and controls ( = 1.45, df = 2, and P = 0.485). The mean PHQ-9 total score of the sample was 8.67 (SD 8.22). There was significant difference in the mean PHQ-9 scores between cases (14.71) and controls (2.55) (t = 13.58, df = 149, and P < 0.001). Classification of cases according to the severity of depression based on the PHQ-9 total score showed that 7 (9.2%) had minimal depression (score 1–4), 12 (15.8%) mild depression (score 5–9), 15 (19.7%) moderate depression (score 10–14), 20 (26.3%) moderately severe depression (score 15–19), and 22 (28.9%) severe depression (score 20–27). Of the controls 61 (81.3%) had minimal depression, 12 (16%) had mild depression, one had moderate depression and another had moderate to severe depression, and none had severe depression.

3.1. Validity

The Structured Clinical Interview for DSM-IV Disorders (SCID-1) was used as the “gold standard” [17]. When the categorical algorithm was used to diagnose major depressive disorder, the sensitivity was 0.58 and the specificity was 0.97 (Table 1).
Table 1

Sensitivity and specificity of the PHQ-9 categorical algorithm.

CasesControls
PHQ-9 positive442
PHQ-9 negative3273
Receiver operating characteristic (ROC) analysis identified sensitivity and specificity at different cut-off points for the diagnostic algorithm using the total score (Figure 1). The area under the curve (AOC) was 0.93. Cut-off score of ≥10 gave a sensitivity of 0.75 and specificity of 0.97 (Table 2).
Figure 1

Receiver operating curve. Diagonal segments are produced by ties.

Table 2

Sensitivity and specificity of PHQ-9 at different cut-off scores.

Cut-off scoreSensitivitySpecificity
≥50.910.81
≥60.880.84
≥70.840.89
≥80.820.92
≥90.790.96
≥100.750.97
≥110.680.97
≥120.670.99
≥130.580.99
≥140.570.99
≥150.550.99
≥160.500.99
Concurrent validity was assessed by correlating the total scores of PHQ-9 and Centre for Epidemiological Studies Depression Scale (CESD). The Pearson correlation coefficient was 0.87. In the two-item categorical algorithm, depression screening is positive if one or more of the two depressive symptom criteria are present. The sensitivity of the two-item screener was 0.80 and the specificity was 0.97 (Table 3).
Table 3

Sensitivity and specificity of the PHQ-2 screener.

CasesControls
PHQ-2 positive612
PHQ-2 negative1573

3.2. Reliability

Cronbach's alpha was 0.90. The mean item scores and corrected item-total correlations are given in Table 4. The mean scores of the items ranged from 0.57 to 1.36. The lowest item mean (0.57) and the lowest item-total correlation (0.44) were for item 6 Feeling bad about yourself or that you are a failure. Cronbach's alpha, if item is removed, reduced for all items.
Table 4

PHQ-9 item mean and item-rest correlation.

MeanStandard deviationCorrected item-total correlationCronbach's alpha if item is removed
Item 1Little interest or pleasure in doing things0.921.280.730.88
Item 2Feeling down, depressed, or hopeless1.361.300.740.88
Item 3Trouble falling or staying asleep or sleeping too much1.251.320.710.88
Item 4Feeling tired or having little energy1.301.320.760.88
Item 5Poor appetite or overeating0.971.250.600.89
Item 6Feeling bad about yourself or that you are a failure0.571.010.440.90
Item 7Trouble concentrating on things0.821.260.620.89
Item 8Moving or speaking so slowly that other people could have noticed0.831.270.700.88
Item 9Thoughts that you would be better off dead or of hurting yourself0.641.050.640.89

4. Discussion

This study examined the validity and reliability of two algorithms of the PHQ-9 and the two-question screener (PHQ-2) in diagnosing major depressive disorder. When the categorical algorithm was used, the sensitivity was 0.58 and the specificity was 0.97. When the threshold algorithm was used, a cut-off score of ≥10 gave a sensitivity of 0.75 and specificity of 0.97. Cronbach's alpha was 0.90 which may indicate the unidimensionality of the scale. The sensitivity of the two-item screener (PHQ-2) was 0.80 and the specificity was 0.97. When the categorical algorithm was used, the PHQ-9 had very high specificity but low sensitivity. There are reports that the categorical algorithm results in low sensitivity (0.42–0.53) but high specificity [11, 20, 21]. The sensitivity and the specificity of a diagnostic test depend on the characteristics of the test and the population in which it is used [22]. Sensitivity is higher when the sample consists of more patients with severe disease. In our sample, although the mean PHQ-9 score was (8.67) higher than that in several other studies, this did not result in high sensitivity. It is possible that in some cultures emotional problems are expressed differently and this can influence the interpretation of scale items. However low sensitivity was seen with the categorical algorithm but not the threshold algorithm. Therefore the low sensitivity of the categorical algorithm may reflect the stringency of criteria for diagnosis rather than problems with interpretation of items. Similar findings have led other researchers to recommend the use of the threshold algorithm rather than the categorical algorithm [11, 20]. It is thought that patients from non-Western cultures are less likely to acknowledge the presence of low mood. Patients with depressive disorder, from both Western and non-Western cultures, have been found to present initially with somatic symptoms such as musculoskeletal pain and fatigue [23]. The mean score of items of the PHQ-9 in our sample showed that somatic symptoms of poor sleep and lack of energy were commonly acknowledged, but the item most frequently reported by the sample was low mood. Therefore, in our sample, regardless of the presenting complaint, patients with depressive disorder did acknowledge experiencing low mood. This finding has been reported from a study in Thailand too [11]. The PHQ-2 screener had high sensitivity and specificity. The sensitivity of the two-item screener (0.80) was higher than that of the categorical algorithm (0.58) and the threshold algorithm (0.75). The specificity was the same as the other two algorithms. The United States Preventive Services Taskforce recommends using the first 2 questions in the PHQ-9 “Over the past 2 weeks, have you felt down, depressed, or hopeless?” and “Over the past 2 weeks, have you felt little interest or pleasure in doing things?” in screening for depression in adults because it may be as effective as using more formal instruments [24, 25]. Our findings show that the PHQ-2 is effective in screening for depression as it has good sensitivity and specificity and can be administered in busy outpatient settings with ease. However it is not recommended for diagnosis of major depressive disorder. Our study has several limitations. We used a case-control design which is known to increase the sensitivity and specificity of the instrument [22]. However the patient sample included an appropriate spectrum of mild and severe disease as well as treated and untreated individuals. A major limitation of the study was that we recruited patients from a tertiary care psychiatry unit. Although this outpatient clinic treated patients who directly present similar to a primary care facility the composition of the patient population would be different to that of a primary care centre. Patients presenting to primary care services may be diagnosed with specific clinical syndromes that vary in duration and severity over time and also encompass an admixture of somatic and psychological symptoms that do not match current psychiatric diagnostic systems [26]. This is especially true for depressive symptoms. For example, pain may be a presenting symptom of depressive disorder in primary care. Therefore instruments and diagnostic criteria may need to be adapted for use in primary care.

5. Conclusions

We recommend the use of the threshold algorithm rather than the categorical algorithm for screening for depressive disorder, because of the better sensitivity of the former. We also recommend the use of the PHQ-2 screener in all clinical settings, because it has high sensitivity and specificity and can be administered easily.
  20 in total

1.  Validity of the Patient Health Questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study.

Authors:  Masatoshi Inagaki; Tsuyuka Ohtsuki; Naohiro Yonemoto; Yoshitaka Kawashima; Akiyoshi Saitoh; Yuetsu Oikawa; Mie Kurosawa; Kumiko Muramatsu; Toshi A Furukawa; Mitsuhiko Yamada
Journal:  Gen Hosp Psychiatry       Date:  2013-09-09       Impact factor: 3.238

Review 2.  Case-control and two-gate designs in diagnostic accuracy studies.

Authors:  Anne W S Rutjes; Johannes B Reitsma; Jan P Vandenbroucke; Afina S Glas; Patrick M M Bossuyt
Journal:  Clin Chem       Date:  2005-06-16       Impact factor: 8.327

3.  Screening for somatization and depression in Saudi Arabia: a validation study of the PHQ in primary care.

Authors:  Susan Becker; Khalid Al Zaid; Eiad Al Faris
Journal:  Int J Psychiatry Med       Date:  2002       Impact factor: 1.210

4.  Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire.

Authors:  R L Spitzer; K Kroenke; J B Williams
Journal:  JAMA       Date:  1999-11-10       Impact factor: 56.272

5.  Validation and utility of the patient health questionnaire in diagnosing mental disorders in 1003 general hospital Spanish inpatients.

Authors:  C Diez-Quevedo; T Rangil; L Sanchez-Planell; K Kroenke; R L Spitzer
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

Review 6.  Recognition of depression by non-psychiatric physicians--a systematic literature review and meta-analysis.

Authors:  Monica Cepoiu; Jane McCusker; Martin G Cole; Maida Sewitch; Eric Belzile; Antonio Ciampi
Journal:  J Gen Intern Med       Date:  2007-10-26       Impact factor: 5.128

Review 7.  Diagnostic accuracy of the mood module of the Patient Health Questionnaire: a systematic review.

Authors:  Karin A Wittkampf; Leonie Naeije; Aart H Schene; Jochanan Huyser; Henk C van Weert
Journal:  Gen Hosp Psychiatry       Date:  2007 Sep-Oct       Impact factor: 3.238

8.  The Patient Health Questionnaire-2: validity of a two-item depression screener.

Authors:  Kurt Kroenke; Robert L Spitzer; Janet B W Williams
Journal:  Med Care       Date:  2003-11       Impact factor: 2.983

9.  Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Theo Vos; Abraham D Flaxman; Mohsen Naghavi; Rafael Lozano; Catherine Michaud; Majid Ezzati; Kenji Shibuya; Joshua A Salomon; Safa Abdalla; Victor Aboyans; Jerry Abraham; Ilana Ackerman; Rakesh Aggarwal; Stephanie Y Ahn; Mohammed K Ali; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Adil N Bahalim; Suzanne Barker-Collo; Lope H Barrero; David H Bartels; Maria-Gloria Basáñez; Amanda Baxter; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Eduardo Bernabé; Kavi Bhalla; Bishal Bhandari; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; James A Black; Hannah Blencowe; Jed D Blore; Fiona Blyth; Ian Bolliger; Audrey Bonaventure; Soufiane Boufous; Rupert Bourne; Michel Boussinesq; Tasanee Braithwaite; Carol Brayne; Lisa Bridgett; Simon Brooker; Peter Brooks; Traolach S Brugha; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Geoffrey Buckle; Christine M Budke; Michael Burch; Peter Burney; Roy Burstein; Bianca Calabria; Benjamin Campbell; Charles E Canter; Hélène Carabin; Jonathan Carapetis; Loreto Carmona; Claudia Cella; Fiona Charlson; Honglei Chen; Andrew Tai-Ann Cheng; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Manu Dahiya; Nabila Dahodwala; James Damsere-Derry; Goodarz Danaei; Adrian Davis; Diego De Leo; Louisa Degenhardt; Robert Dellavalle; Allyne Delossantos; Julie Denenberg; Sarah Derrett; Don C Des Jarlais; Samath D Dharmaratne; Mukesh Dherani; Cesar Diaz-Torne; Helen Dolk; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Karen Edmond; Alexis Elbaz; Suad Eltahir Ali; Holly Erskine; Patricia J Erwin; Patricia Espindola; Stalin E Ewoigbokhan; Farshad Farzadfar; Valery Feigin; David T Felson; Alize Ferrari; Cleusa P Ferri; Eric M Fèvre; Mariel M Finucane; Seth Flaxman; Louise Flood; Kyle Foreman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Belinda J Gabbe; Sherine E Gabriel; Emmanuela Gakidou; Hammad A Ganatra; Bianca Garcia; Flavio Gaspari; Richard F Gillum; Gerhard Gmel; Richard Gosselin; Rebecca Grainger; Justina Groeger; Francis Guillemin; David Gunnell; Ramyani Gupta; Juanita Haagsma; Holly Hagan; Yara A Halasa; Wayne Hall; Diana Haring; Josep Maria Haro; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Hideki Higashi; Catherine Hill; Bruno Hoen; Howard Hoffman; Peter J Hotez; Damian Hoy; John J Huang; Sydney E Ibeanusi; Kathryn H Jacobsen; Spencer L James; Deborah Jarvis; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Jost B Jonas; Ganesan Karthikeyan; Nicholas Kassebaum; Norito Kawakami; Andre Keren; Jon-Paul Khoo; Charles H King; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Ratilal Lalloo; Laura L Laslett; Tim Lathlean; Janet L Leasher; Yong Yi Lee; James Leigh; Stephen S Lim; Elizabeth Limb; John Kent Lin; Michael Lipnick; Steven E Lipshultz; Wei Liu; Maria Loane; Summer Lockett Ohno; Ronan Lyons; Jixiang Ma; Jacqueline Mabweijano; Michael F MacIntyre; Reza Malekzadeh; Leslie Mallinger; Sivabalan Manivannan; Wagner Marcenes; Lyn March; David J Margolis; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; Neil McGill; John McGrath; Maria Elena Medina-Mora; Michele Meltzer; George A Mensah; Tony R Merriman; Ana-Claire Meyer; Valeria Miglioli; Matthew Miller; Ted R Miller; Philip B Mitchell; Ana Olga Mocumbi; Terrie E Moffitt; Ali A Mokdad; Lorenzo Monasta; Marcella Montico; Maziar Moradi-Lakeh; Andrew Moran; Lidia Morawska; Rintaro Mori; Michele E Murdoch; Michael K Mwaniki; Kovin Naidoo; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Paul K Nelson; Robert G Nelson; Michael C Nevitt; Charles R Newton; Sandra Nolte; Paul Norman; Rosana Norman; Martin O'Donnell; Simon O'Hanlon; Casey Olives; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Andrew Page; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Scott B Patten; Neil Pearce; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; Konrad Pesudovs; David Phillips; Michael R Phillips; Kelsey Pierce; Sébastien Pion; Guilherme V Polanczyk; Suzanne Polinder; C Arden Pope; Svetlana Popova; Esteban Porrini; Farshad Pourmalek; Martin Prince; Rachel L Pullan; Kapa D Ramaiah; Dharani Ranganathan; Homie Razavi; Mathilda Regan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Kathryn Richardson; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Felipe Rodriguez De Leòn; Luca Ronfani; Robin Room; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Sukanta Saha; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; David C Schwebel; James Graham Scott; Maria Segui-Gomez; Saeid Shahraz; Donald S Shepard; Hwashin Shin; Rupak Shivakoti; David Singh; Gitanjali M Singh; Jasvinder A Singh; Jessica Singleton; David A Sleet; Karen Sliwa; Emma Smith; Jennifer L Smith; Nicolas J C Stapelberg; Andrew Steer; Timothy Steiner; Wilma A Stolk; Lars Jacob Stovner; Christopher Sudfeld; Sana Syed; Giorgio Tamburlini; Mohammad Tavakkoli; Hugh R Taylor; Jennifer A Taylor; William J Taylor; Bernadette Thomas; W Murray Thomson; George D Thurston; Imad M Tleyjeh; Marcello Tonelli; Jeffrey A Towbin; Thomas Truelsen; Miltiadis K Tsilimbaris; Clotilde Ubeda; Eduardo A Undurraga; Marieke J van der Werf; Jim van Os; Monica S Vavilala; N Venketasubramanian; Mengru Wang; Wenzhi Wang; Kerrianne Watt; David J Weatherall; Martin A Weinstock; Robert Weintraub; Marc G Weisskopf; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Sean R M Williams; Emma Witt; Frederick Wolfe; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Anita K M Zaidi; Zhi-Jie Zheng; David Zonies; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

10.  Reliability and validity of the Thai version of the PHQ-9.

Authors:  Manote Lotrakul; Sutida Sumrithe; Ratana Saipanish
Journal:  BMC Psychiatry       Date:  2008-06-20       Impact factor: 3.630

View more
  15 in total

1.  Validating the Patient Health Questionnaire-9 (PHQ-9) for screening of depression in Tanzania.

Authors:  Mary C Smith Fawzi; Fileuka Ngakongwa; Yuanyuan Liu; Theonest Rutayuga; Hellen Siril; Magreat Somba; Sylvia F Kaaya
Journal:  Neurol Psychiatry Brain Res       Date:  2018-11-18

2.  The theoretical and practical determination of clinical cut-offs for the British Sign Language versions of PHQ-9 and GAD-7.

Authors:  Rachel A Belk; Mark Pilling; Katherine D Rogers; Karina Lovell; Alys Young
Journal:  BMC Psychiatry       Date:  2016-11-03       Impact factor: 3.630

3.  An arabic translation, reliability, and validation of Patient Health Questionnaire in a Saudi sample.

Authors:  Ahmad N AlHadi; Deemah A AlAteeq; Eman Al-Sharif; Hamdah M Bawazeer; Hasan Alanazi; Abdulaziz T AlShomrani; Raafat M Shuqdar; Reem AlOwaybil
Journal:  Ann Gen Psychiatry       Date:  2017-09-06       Impact factor: 3.455

4.  Prevalence and associations of depression among patients with cardiac diseases in a public health institute in Trinidad and Tobago.

Authors:  Mandreker Bahall
Journal:  BMC Psychiatry       Date:  2019-01-07       Impact factor: 3.630

5.  Childhood adversity and deliberate self-poisoning in Sri Lanka: a protocol for a hospital-based case-control study.

Authors:  Duleeka W Knipe; Piumee Bandara; Lalith Senarathna; Judi Kidger; José López-López; Thilini Rajapakse
Journal:  BMJ Open       Date:  2019-08-18       Impact factor: 2.692

6.  Depressive disorder and grief following spontaneous abortion.

Authors:  Susil Kulathilaka; Raveen Hanwella; Varuni A de Silva
Journal:  BMC Psychiatry       Date:  2016-04-12       Impact factor: 3.630

7.  Depression literacy of undergraduates in a non-western developing context: the case of Sri Lanka.

Authors:  Santushi D Amarasuriya; Anthony F Jorm; Nicola J Reavley
Journal:  BMC Res Notes       Date:  2015-10-22

8.  Translation and Validation of the Sinhalese Version of the Brief Medication Questionnaire in Patients with Diabetes Mellitus.

Authors:  P Ranasinghe; R Jayawardena; P Katulanda; G R Constantine; V Ramanayake; P Galappatthy
Journal:  J Diabetes Res       Date:  2018-05-23       Impact factor: 4.011

9.  Criterion-related validity and reliability of the Urdu version of the patient health questionnaire in a sample of community-based pregnant women in Pakistan.

Authors:  John A Gallis; Joanna Maselko; Karen O'Donnell; Ke Song; Kiran Saqib; Elizabeth L Turner; Siham Sikander
Journal:  PeerJ       Date:  2018-07-17       Impact factor: 2.984

10.  Study protocol: a pilot randomized controlled trial to evaluate the acceptability and feasibility of a counseling intervention, delivered by nurses, for those who have attempted self-poisoning in Sri Lanka.

Authors:  A N L M De Silva; Andrew H Dawson; Indika B Gawarammana; Sampath Tennakoon; Thilini Rajapakse
Journal:  Pilot Feasibility Stud       Date:  2018-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.